Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil.

By Negrier S.   Caty A.   Lesimple T.   J-Y D.   Escudier B.   J-F R.   Viens P.   Gomez F.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 84-84

Elsevier

Access to resources Recommend Favorite

Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer - a phase II study.

By Allen M.   Vaughan M.   Webb A.   Johnston S.   Savage P.   Eisen T.   Bates S.   Morre J.   Ahern R.   Gore M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 2, 2002-03 ,pp. : 83-83

Elsevier

Access to resources Recommend Favorite

Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon- after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen

By Atzpodien J.   Lopez Hanninen E.   Kirchner H.   Franzke A.   Korfer A.   Volkenandt M.   Duensing S.   Schomburg A.   Chaitchik S.   Poliwoda H.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 876-881

Elsevier

Access to resources Recommend Favorite

Subcutaneous Recombinant Interleukin-2 Plus Chemotherapy with Cisplatin and Dacarbazine in Metastatic Melanoma

By Guida M.   Latorre A.   Mastria A.   De Lena M.  

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 730-733

Elsevier

Access to resources Recommend Favorite

Feasibility of prior administration of cyclophosphamide in TC combination treatment

By Abe Hajime   Kawai Yuki   Mori Tsuyoshi   Cho Hirotomi   Kubota Yoshihiro   Umeda Tomoko   Tani Tohru  

Breast Cancer, Vol. 21, Iss. 2, 2014-03 ,pp. : 202-207

Springer Publishing Company

Access to resources Recommend Favorite